Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study

Annals of Oncology

Volumn 7, Issue 8, 1996, Pages 857-860

  Michelotti, A ^a   Gennari, A ^a   Salvadori, B ^a   Tognoni, A ^a   Tibaldi, C ^a   Baldini, E ^a   Conte, P F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Breast cancer; Paclitaxel; Vinorelbine

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CIMETIDINE; DIPHENYLHYDRAZINE; NAVELBINE; PACLITAXEL; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALOPECIA; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

EID: 0029909870     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010767     Document Type: Article

References (12)

1. Henderson IC. Chemotherapy for advanced disease. In Harris JR, Hellmann S, Henderson IC et al. (eds): Breast Diseases. Philadelphia, PA: Lippincott 1987; 428-79.
2. Holmes FA, Walters RS, Theriault RL et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991; 83: 1797-805.
3. Reichman BS, Seidman AD, Crown JPA et al. Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 1993; 11: 1943-51.
4. Seidman AD, Norton L, Reichman BS et al. Preliminary experience with paclitaxel plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer. Semin Oncol 1993; 20 (Suppl 3): 40-4.
5. Gelman K, Nabholtz JM, Bontenbal M et al. Randomized trial of two doses of paclitaxel in metastatic breast cancer after failure of standard therapy. Ann Oncol 1994; 5 (Suppl 5): 493 (Abstr 198).
6. Gianni L, Munzone E, Capri G et al. Paclitaxel in metastatic breast cancer: A trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst 1995; 87: 1169-75.
7. Seidman AD, Tiersten A, Hudis C et al. Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 1995; 13: 2575-81.
8. Gasparini G, Caffo O, Barni S et al. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study. J Clin Oncol 1994; 12: 2094-101.
9. Degardin M, Bonneterre J, Hecquet B et al. Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer. Ann Oncol 1994; 5: 423-26.
10. Romero A, Rabinovich MG, Vallejo CT et al. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 1994; 12: 336-41.
11. Weber BL, Vogel C, Jones S et al. Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 1995; 13: 2722-30.
12. Longo DL, Duffey PL, De Vita VT Jr et al. The calculation of actual or received dose intensity: A comparison of published methods. J Clin Oncol 1991; 9: 2042-51.